van der Kamp Hilde Johanna 4
4 · NewAmsterdam Pharma Co N.V. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
van der Kamp Hilde Johanna
Director
Transactions
- Award
Option (right to buy)
2024-01-01+10,000→ 10,000 totalExercise: $11.17Exp: 2034-01-01→ Ordinary Shares (10,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the option will vest on January 1, 2025, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.